arrow
Back
王

王建祥 (Jianxiang Wang)

Chinese Academy of Medical Sciences and Peking Union Medical College

57H-index
849Paper Count
1.8WCitation Count
Published Papers 189
Publication Date
Transcriptome Analysis Identifies a Myeloid‐Like Signature in Relapsed or Refractory B ‐Cell Acute Lymphoblastic Leukemia Patients With Poor Response to CD19 Chimeric Antigen Receptor T Cell Therapy
err2026-10-19
err0
errOAAI
errShisen Wang; Wenbing Liu; Ying Wang; Yingxi Xu; Haiyan Xing; Kejing Tang; Zheng Tian; Qing Rao; Shaowei Qiu; Hui Wei; Runxia Gu; Min Wang; Jianxiang Wang
errShare
errSave
Subtype‐ and functional class‐dependent prognostic impact of CSF3R mutations in acute myeloid leukaemia: A cohort study of 2500 patients
err2026-10-18
err0
PREAI
errJingyao An; Yan Hui; Yan Li; Ying Wang; Benfa Gong; Yuntao Liu; Shouyun Li; Dong Lin; Kaiqi Liu; Guangji Zhang; Chunlin Zhou; Xiaoyuan Gong; Shaowei Qiu; Bingcheng Liu; Yingchang Mi; Qiuyun Fang; Jianxiang Wang; Hui Wei
errShare
errSave
Author Correction: Proteasome-guided haem signalling axis contributes to T cell exhaustion
errNature
IF48.5
err2026-09-29
err0
PREAI
errYingxi Xu; Yangtao Shangguan; Yu-Ming Chuang; Tzu-Hsuan Chang; Wenbing Liu; Jhan-Jie Peng; Josep Garnica; Leling Xie; Pei-Chun Hsueh; Mei-Chun Lin; Yi-Hao Wang; Karina Lobo Hajdu; Yibo Wu; Maryam Akrami; Chen Wang; Anna Kohl; Alfred Zippelius; Wei Qi; Min Wang; Bugi Ratno Budiarto; Shih-Yu Chen; Zhengtao Xiao; Panagiota Vardaka; Rahul Roychoudhuri; Zhiliang Bai; Rong Fan; Santiago Carmona; Yi-Ru Yu; Christoph Scheiermann; Jianxiang Wang; Ping-Chih Ho
errShare
errSave
Fluorescently labeled Angiopep-2-conjugated-PAMAM nanoparticles to evaluate drug brain-targeted delivery performance
err2026-09-02
err0
PREAI
errXingyue Li; Jianxiang Wang; Yifei Wang; Fangfang Hu; Xin Yang; Jingjing Zhang; Haiyan Dong; Wen Lu
errShare
errSave
Asciminib Provides Better Efficacy and Favorable Safety and Tolerability Against Investigator-Selected Tyrosine Kinase Inhibitors in East Asian Patients With Newly Diagnosed Chronic Myeloid Leukemia: Results From a Subgroup Analysis of the Pivotal ASC4FIRST Study
err2026-06-24
err0
errOAAI
errNaoto Takahashi; Dong-Wook Kim; Inho Kim; Xin Du; Sung-Eun Lee; Yu Hu; Yoshikane Kikushige; Qian Jiang; Yi Wang; Suning Chen; Huanling Zhu; Tatsunori Goto; Akihiro Tomita; Michiko Ichii; Hirohisa Nakamae; Lei Liu; Beini Liu; Kamel Malek; Tong Zhu; Shengyuan Wu; Jianxiang Wang
errShare
errSave
Venetoclax Plus Pediatric Regimen in Adolescents and Adults with Ph-Negative Acute Lymphoblastic Leukemia
errBlood
IF23.1
err2026-05-25
err0
PREAI
errXiaoyuan Gong; Yuntao Liu; Qiuyun Fang; Runxia Gu; Kaiqi Liu; Dong Lin; Chunlin Zhou; Guangji Zhang; Benfa Gong; Shuning Wei; Yan Li; Shouyun Li; Ying Wang; Shaowei Qiu; Bingcheng Liu; Ying Wang; Yingchang Mi; Hui Wei; Jianxiang Wang
errShare
errSave
Author Correction: Proteasome-guided haem signalling axis contributes to T cell exhaustion
errNature
IF48.5
err2026-05-07
err0
PREAI
errYingxi Xu; Yangtao Shangguan; Yu-Ming Chuang; Tzu-Hsuan Chang; Wenbing Liu; Jhan-Jie Peng; Josep Garnica; Leling Xie; Pei-Chun Hsueh; Mei-Chun Lin; Yi-Hao Wang; Karina Lobo Hajdu; Yibo Wu; Maryam Akrami; Chen Wang; Anna Kohl; Alfred Zippelius; Wei Qi; Min Wang; Bugi Ratno Budiarto; Shih-Yu Chen; Zhengtao Xiao; Panagiota Vardaka; Rahul Roychoudhuri; Zhiliang Bai; Rong Fan; Santiago Carmona; Yi-Ru Yu; Christoph Scheiermann; Jianxiang Wang; Ping-Chih Ho
errShare
errSave
Daunorubicin-45 Vs. Daunorubicin-60 for Induction in Intermediate-Age Patients of AML: Results From a Randomized Trial
err2026-04-15
err0
errOAAI
errChunlin Zhou; Le Li; Yan Li; Kaiqi Liu; Yuntao Liu; Dong Lin; Benfa Gong; Guangji Zhang; Xiaoyuan Gong; Qiuyun Fang; Bingcheng Liu; Shaowei Qiu; Ying Wang; Hui Wei; Yingchang Mi; Jianxiang Wang
errShare
errSave
Active Rac1-Mediated Bone Marrow Retention Enhances CD33 CAR-T Cell Efficacy Against CD33+ Leukemia Cells
err2026-04-10
err0
PREAI
errShangshang Wang; Le Li; Haiyan Xing; Yingxi Xu; Zhifeng Yan; Haotian Ma; Heye Yu; Fan Ding; Kejing Tang; Zheng Tian; Shaowei Qiu; Ying Wang; Min Wang; Qing Rao; Runxia Gu; Jianxiang Wang
errShare
errSave
Quizartinib in newly diagnosed patients with FLT3-ITD–positive AML who received maintenance therapy in QuANTUM-First
err2026-04-09
err0
errOAAI
errMark J. Levis; Harry P. Erba; Pau Montesinos; Elżbieta Patkowska; Jorge Cortes; Alexander E. Perl; Hervé Dombret; Sergio Amadori; Jianxiang Wang; Richard F. Schlenk; Li Liu; Yasser Mostafa Kamel; Karima Imadalou; Abderrahmane Laadem; Kristy Burns; Mikkael A. Sekeres
errShare
errSave
errShare
errSave
Proteasome-guided haem signalling axis contributes to T cell exhaustion
errNature
IF48.5
err2026-03-18
err0
PREAI
errYingxi Xu; Yangtao Shangguan; Yu-Ming Chuang; Tzu-Hsuan Chang; Wenbing Liu; Jhan-Jie Peng; Josep Garnica; Leling Xie; Pei-Chun Hsueh; Mei-Chun Lin; Yi-Hao Wang; Karina Lobo Hajdu; Yibo Wu; Maryam Akrami; Chen Wang; Anna Kohl; Alfred Zippelius; Wei Qi; Min Wang; Bugi Ratno Budiarto; Shih-Yu Chen; Zhengtao Xiao; Panagiota Vardaka; Rahul Roychoudhuri; Zhiliang Bai; Rong Fan; Santiago Carmona; Yi-Ru Yu; Christoph Scheiermann; Jianxiang Wang; Ping-Chih Ho
errShare
errSave
Phase 1 trial of BCL-2 inhibitor lisaftoclax (APG-2575) in Chinese patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma and other non-Hodgkin lymphomas
err2026-03-17
err0
PREAI
errMingyuan Sun; Keshu Zhou; Junyuan Qi; Huilan Liu; Aizong Shen; Liangquan Geng; Fuling Zhou; Jianying Huang; Zi Chen; Ke Zhang; Lichuang Men; Danhua Cong; Fang Lu; Dajun Yang; Yifan Zhai; Jianxiang Wang
errShare
errSave
Long-term follow-up of predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia in the phase 3 COMMODORE trial
err2026-01-12
err0
errOAAI
errBin Jiang; Jian Li; Ligen Liu; Xin Du; Hao Jiang; Jianda Hu; Xiaoxi Zeng; Taishi Sakatani; Masanori Kosako; Yaru Deng; Vladimir Ivanov; Sergey Bondarenko; Lily Wong Lee Lee; Archrob Khuhapinant; Elena Martynova; Nahla Hasabou; Jamie Jung-Hee An; Jianxiang Wang
errShare
errSave
Clonal architecture of FLT3-ITD and acquired 13q uniparental disomy define prognostic heterogeneity and therapeutic vulnerabilities in acute myeloid leukemia
err2025-12-17
err0
errOAAI
errAnli Lai; Wenbing Liu; Yihan Mei; Qimin Zhang; Junping Zhang; Kejing Tang; Qing Rao; Runxia Gu; Sizhou Feng; Ying Wang; Min Wang; Hui Wei; Yingchang Mi; Shaowei Qiu; Jianxiang Wang
errShare
errSave
Asciminib Demonstrates Superior Efficacy and Safety in Newly Diagnosed Chronic Myeloid Leukemia in ASC4FIRST
errBlood
IF23.1
err2025-12-17
err0
errOAAI
errJorge E. Cortes; Timothy P. Hughes; Jianxiang Wang; Dong-Wook Kim; Dennis Dong Hwan Kim; Jiri Mayer; Yeow-Tee Goh; Philipp le Coutre; Gabriel Etienne; Inho Kim; David J. Andorsky; Felice Bombaci; Ghayas C. Issa; Naoto Takahashi; Shruti Kapoor; Rajendra Jinwal; Kamel Malek; Tracey McCulloch; Lillian Yau; Richard A. Larson
errShare
errSave
Measurable residual disease recurrence as early warning of relapse in acute myeloid leukemia
err2025-12-01
err2
errOAAI
errGong, Benfa; Yang, Miao; Qiu, Shaowei; Liu, Bingcheng; Wang, Ying; Mi, Yingchang; Wei, Hui; Wang, Jianxiang
errShare
errSave
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy
err2025-11-24
err0
errOAAI
errAndrew H. Wei; Panayiotis Panayiotidis; Pau Montesinos; Kamel Laribi; Vladimir Ivanov; Inho Kim; Jan Novak; Rebecca Champion; Walter Fiedler; Maria Pagoni; Julie Bergeron; Stephen B. Ting; Jing-Zhou Hou; Takahiro Yamauchi; Jianxiang Wang; Stephen A. Strickland; Michael R. Savona; Tara L. Lin; Anoop Enjeti; Ing Soo Tiong
errShare
errSave
Progression significance for low-level aberrant B-lymphoblasts in chronic myeloid leukaemia patients
err2025-11-05
err0
errOAAI
errHaoren Wang; Huijun Wang; Yuanyuan Li; Bin Zheng; Qiuyun Fang; Yan Li; Yuntao Liu; Runxia Gu; Ying Wang; Yingchang Mi; Bingcheng Liu; Hui Wei; Jianxiang Wang
errShare
errSave
Does Corporate ESG Performance Enhance Sustained Green Innovation? Empirical Evidence from China
err2025-10-15
err0
PREAI
errWang, Xueqing; Shi, Yongdong; Wang, Jianxiang; Wang, Guiliang; Wei, Zeshuai; Li, Jingyi
errShare
errSave

Research Directions

白血病的临床与基础研究,探索白血病的发病机理靶向治疗和预后危险度分层治疗